A randomized, double-blind, placebo-controlled trial of st john's wort for treating irritable bowel syndrome

American Journal of Gastroenterology

Volumn 105, Issue 1, 2010, Pages 170-177

  Saito, Yuri A ^a   Rey, Enrique ^a   Almazar Elder, Ann E ^a   Harmsen, W Scott ^a   Zinsmeister, Alan R ^a   Locke, G Richard ^a   Talley, Nicholas J ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERICUM PERFORATUM EXTRACT; PLACEBO;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BLOATING; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEARTBURN; HERBAL MEDICINE; HUMAN; HYPERICUM PERFORATUM; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SELF REPORT; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERICUM; IRRITABLE BOWEL SYNDROME; LOGISTIC MODELS; MALE; MIDDLE AGED; PHYTOTHERAPY; PLACEBOS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 73849085585     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.577     Document Type: Article

References (41)

1. Saito YA, Schoenfeld P, Locke GR III. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 2002;97:1910-1915 (Pubitemid 34906835)
2. Talley N J, Gabriel SE, Harmsen W S et al. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995;109:1736-1741
3. El-Serag HB, Olden K, Bjorkman D. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ter 2002;16:1171-1185
4. Drossman D A, Camilleri M, Mayer E A et al. AGA technical reviewon irritable bowel syndrome. Gastroenterology 2002;123:2108-2131 (Pubitemid 35408332)
5. Donker GA, Foets M, Spreeuwenberg P. Patients with irritable bowel syndrome: health status and use of health care services. Br J Gen Pract 1999;49:787-792
6. Vandvik PO, Lydersen S, Farup PG. Prevalence, comorbidity and impact of irritable bowel syndrome in Norway. Scand J Gastroenterol 2006;41:650-656
7. van Tilburg M A L, Palsson O S, Levy R L et al. Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO. BMC Complement Altern Med 2008;8:46.
8. Koloski N A, Talley N J, Huskic S S et al. Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ter 2003;17:841-851
9. Carmona-Sanchez R, Tostado-Fernandez F. [Prevalence of use oflalternative and complementary medicine in patients with irritable bowel syndrome, functional dyspepsia and gastroesophageal refux disease]. Rev Gastroenterol Mex 2005;70:393-398
10. Jarrett M E, Heitkemper M M, Hertig V et al.A ltern ative h ealth care practices in women with irritable bowel syndrome. Gastroenterology 1999;116:A1012.
11. Smart HL, Mayberry JF, Atkinson M. Alternative medicine consultations and remedies in patients with the irritable bowel syndrome. Gut 1986;27:826-828
12. Kong SC, Hurlstone D P, Pocock C Y et al. The incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases. J Clin Gastroenterol 2005;39:138-141
13. Pittler MH, Ernst E, Liu JH et al. Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis. Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial. Am J Gastroenterol 1998;93:1131-1135
14. Bensoussan A, Talley N J, Hing M et al. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA 1998;280:1585-1589
15. Bundy R, Walker A F, Middleton R W et al. Artichoke leaffextract reduces symptoms of irritable bowel syndrome and improves quality of life in otherwise healthy volunteers suffering from concomitant dyspepsia: a subset analysis. J Altern Complement Med 2004;10:667-669
16. Linde K, Berner M M, Kriston L. St John'swort for major depression. Cochrane Database of Systematic Review 2008, Issue 3. Article no. CD000448.
17. Masand P S, Kaplan D S, Gupta S et al. Major depression and irritable bowel syndrome: is there a relationship? J Clin Psychiatry 1995; 56: 363-367
18. Muller WE, Rossol R. Effects of hypericum extract on the expression of serotonin receptors. J Geriatr Psychiatry Neurol 1994; 7 (Suppl 1): S63-4.
19. Neary JT, Bu Y. Hypericum LI 160 inhibits uptake of serotonin and nore-pinephrine in astrocytes. Brain Res 1999;816:358-363
20. Franklin M, Chi J, McGavin C et al. Neuroendocrine evidence for dopaminergic actions of hypericum extract (LI 160) in healthy volunteers. Biol Psychiatry 1999; 46: 581-584
21. Gobbi M, Valle F D, Ciapparelli C et al. Hypericum perforatum L. extract does not inhibit 5-HT1 transporter in rat brain cortex. Naunyn-Schmiedebergs Arch Pharmacol 1999;360:262-269
22. Theuffel Mayer R, Gleitz J. Effects of long-term administration of hypericum extracts on the af nity and density of the central serotonergic 5-HT1 A and 5-HT2 A receptors. Pharmacopsychiatry 1997; 30 (Suppl 2): 113-116
23. Muller WE, Rolli M, Schafer C et al. Effects of hypericum extract (LI 160) in biochemical models oflantidepressant activity. Pharmacopsychiatry 1997;30 (Suppl 2): 102-107
24. Yu P H. Effect of the Hypericum perforatum extract on serotonin turnover in the mouse brain. Pharmacopsychiatry 2000;33:60-65
25. Gershon M D, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterol-ogy 2007;132:397-414.
26. Jackson JL, O 'Malley P G, Tomkins G et al. Treatmentoffunctional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 2000;108:65-72.
27. Tack J, Muller-Lissner S, Bytzer P et al. A randomised controlled trial assessing the eficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation. Gut 2005;54:1707-1713
28. Rahimi R, Nikfar S, Abdollahi M. Eficacy and tolerability oflalosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis offeight randomized, placebo-controlled, 12-week trials. Clin Ter 2008;30:884-901.
29. Drossman D. Tefunctionalgastrointestinaldisorders,theirdiagnosisandthe Rome IIprocess. In: Drossman D, Talley N, Tompson W, et al. (eds). Rome II: The Functional Gastrointestinal Disorders: Diagnosis, Pathophysi-ology and Treatment. A Multinational Consensus., 2 ed Degnon Associates: M cL ean, V A, 2000 p. 1-29.
30. Bijkerk C J,de Wit N J, Muris J W et al. Outcome measures in irritable bowel syndrome: comparison of psychometric and methodological characteristics. Am J Gastroenterol 2003;98:122-127
31. Drossman D A, Patrick D L, Whitehead W E et al. Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol 2000;95:999-1007.
32. Patrick D L, Drossman D A, Frederick IO et al. Qualityoflifeinpersons with irritable bowel syndrome: development and validation ofla new measure. Dig Dis Sci 1998;43:400-411
33. Haringsma R, Engels G I, Beekman A Thet al. The criterion validity of the Center for Epidemiological Studies Depression Scale (CES-D) in a sample of self-referred elders with depressive symptomatology. Int J Geriatr Psychiatry 2004;19:558-563
34. Sallon S, Ben-Arye E, Davidson R et al. A novel treatment for constipation-predominant irritable bowel syndrome using Padma Lax, a Tibetan herbal formula. Digestion 2002;65:161-171
35. Madisch A, Holtmann G, Plein K et al. Treatment of irritable bowel syndrome with herbal preparations: results ofla double-blind, randomized, placebo-controlled, multi-centre trial. Aliment Pharmacol Ter 2004;19:271-279
36. Brinkhaus B, Hentschel C, Von Keudell C et al. Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome: a randomized, placebo-controlled, double-blind clinical trial. Scand J Gastroenterol 2005;40:936-943
37. Leung W K, Wu JC Y, Liang SM et al. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial. Am J Gastroenterol 2006; 101: 1574-1580
38. Davis K, Philpott S, Kumar D et al. Randomised double-blind placebo-controlled trial oflaloe vera for irritable bowel syndrome. Int J Clin Pract 2006;60:1080-1086
39. Szegedi A, Kohnen R, Dienel A et al. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine. [see comment][erratum appears in BMJ. 2005 Apr 2; 330 (7494):759 Note: dosage error in text]. BMJ 2005; 330: 503.
40. Dorn S D, Kaptchuk T J, Park JB et al. A meta-analysis of the placebo response in complementary and alternative medicine trials of irritable bowel syndrome. Neurogastroenterol Motil 2007;19:630-637
41. Chang L, Heitkemper M M. Gender differences inirritable bowel syndrome. Gastroenterology 2002;123:1686-1701